These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34453544)

  • 1. Modern History of Cholera Vaccines and the Pivotal Role of icddr,b.
    Holmgren J
    J Infect Dis; 2021 Dec; 224(12 Suppl 2):S742-S748. PubMed ID: 34453544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A thermostable, dry formulation inactivated Hikojima whole cell/cholera toxin B subunit oral cholera vaccine.
    Terrinoni M; Nordqvist SL; Löfstrand M; Nilsson F; Källgård S; Sharma T; Lebens MR; Holmgren J
    Vaccine; 2023 May; 41(21):3347-3357. PubMed ID: 37085452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Hillchol®, a low-cost inactivated single strain Hikojima oral cholera vaccine.
    Sharma T; Joshi N; Kumar Mandyal A; Nordqvist SL; Lebens M; Kanchan V; Löfstrand M; Jeverstam F; Mainul Ahasan M; Khan I; Karim M; Muktadir H; Muktadir A; Gill D; Holmgren J
    Vaccine; 2020 Nov; 38(50):7998-8009. PubMed ID: 33139137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, non-inferiority trial comparing two bivalent killed, whole cell, oral cholera vaccines (Euvichol vs Shanchol) in the Philippines.
    Baik YO; Choi SK; Olveda RM; Espos RA; Ligsay AD; Montellano MB; Yeam JS; Yang JS; Park JY; Kim DR; Desai SN; Singh AP; Kim IY; Kim CW; Park SN
    Vaccine; 2015 Nov; 33(46):6360-5. PubMed ID: 26348402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase I/II study to evaluate safety, tolerability and immunogenicity of Hillchol®, an inactivated single Hikojima strain based oral cholera vaccine, in a sequentially age descending population in Bangladesh.
    Chowdhury F; Ali Syed K; Akter A; Rahman Bhuiyan T; Tauheed I; Khaton F; Biswas R; Ferdous J; Al Banna H; Ross AG; Mc Millan N; Sharma T; Kanchan V; Pal Singh A; Gill D; Lebens M; Nordqvist S; Holmgren J; Clemens JD; Qadri F
    Vaccine; 2021 Jul; 39(32):4450-4457. PubMed ID: 34218960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Update on Cholera Immunity and Current and Future Cholera Vaccines.
    Holmgren J
    Trop Med Infect Dis; 2021 Apr; 6(2):. PubMed ID: 33925118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient Intestinal Colonization by a Live-Attenuated Oral Cholera Vaccine Induces Protective Immune Responses in Streptomycin-Treated Mice.
    Fakoya B; Sit B; Waldor MK
    J Bacteriol; 2020 Nov; 202(24):. PubMed ID: 32540930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of systemic, mucosal and memory antibody responses targeting Vibrio cholerae O1 O-specific polysaccharide (OSP) in adults following oral vaccination with an oral killed whole cell cholera vaccine in Bangladesh.
    Akter A; Dash P; Aktar A; Jahan SR; Afrin S; Basher SR; Hakim A; Lisa AK; Chowdhury F; Khan AI; Xu P; Charles RC; Kelly M; Kováč P; Harris JB; Bhuiyan TR; Calderwood SB; Ryan ET; Qadri F
    PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007634. PubMed ID: 31369553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal and systemic immune responses to
    Naidu A; Lulu S S
    Expert Rev Clin Immunol; 2022 Dec; 18(12):1307-1318. PubMed ID: 36255170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut Microbiota and Development of Vibrio cholerae-Specific Long-Term Memory B Cells in Adults after Whole-Cell Killed Oral Cholera Vaccine.
    Chac D; Bhuiyan TR; Saha A; Alam MM; Salma U; Jahan N; Chowdhury F; Khan AI; Ryan ET; LaRocque R; Harris JB; Qadri F; Weil AA
    Infect Immun; 2021 Aug; 89(9):e0021721. PubMed ID: 34228490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-galactosylceramide enhances mucosal immunity to oral whole-cell cholera vaccines.
    Davitt CJH; Longet S; Albutti A; Aversa V; Nordqvist S; Hackett B; McEntee CP; Rosa M; Coulter IS; Lebens M; Tobias J; Holmgren J; Lavelle EC
    Mucosal Immunol; 2019 Jul; 12(4):1055-1064. PubMed ID: 30953000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral cholera vaccines and their impact on the global burden of disease.
    Wierzba TF
    Hum Vaccin Immunother; 2019; 15(6):1294-1301. PubMed ID: 30183486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
    Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
    Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttranslational Regulation of IL-23 Production Distinguishes the Innate Immune Responses to Live Toxigenic versus Heat-Inactivated Vibrio cholerae.
    Weil AA; Ellis CN; Debela MD; Bhuiyan TR; Rashu R; Bourque DL; Khan AI; Chowdhury F; LaRocque RC; Charles RC; Ryan ET; Calderwood SB; Qadri F; Harris JB
    mSphere; 2019 Aug; 4(4):. PubMed ID: 31434744
    [No Abstract]   [Full Text] [Related]  

  • 16. Why do we not yet have a suitable vaccine against cholera?
    Finkelstein RA
    Adv Exp Med Biol; 1995; 371B():1633-40. PubMed ID: 7502872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An oral B subunit: whole cell vaccine against cholera.
    Holmgren J; Svennerholm AM; Jertborn M; Clemens J; Sack DA; Salenstedt R; Wigzell H
    Vaccine; 1992; 10(13):911-4. PubMed ID: 1471411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical analysis of compositions and protective efficacies of oral killed cholera vaccines.
    Kabir S
    Clin Vaccine Immunol; 2014 Sep; 21(9):1195-205. PubMed ID: 25056361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unmasking herd protection by an oral cholera vaccine in a cluster-randomized trial.
    Ali M; Qadri F; Kim DR; Islam T; Im J; Ahmmed F; Chon Y; Islam Khan A; Zaman K; Marks F; Clemens JD
    Int J Epidemiol; 2019 Aug; 48(4):1252-1261. PubMed ID: 30968110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and future cholera vaccines.
    Shaikh H; Lynch J; Kim J; Excler JL
    Vaccine; 2020 Feb; 38 Suppl 1():A118-A126. PubMed ID: 31879125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.